Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
12/2003
12/11/2003WO2003101394A2 Defensins: use as antiviral agents
12/11/2003WO2003101173A2 Immunomodulatory constructs and their uses
12/11/2003WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method
12/11/2003WO2002098914A3 Mutants of igf binding proteins and methods of production of antagonists thereof
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery
12/11/2003US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228623 For rapid production of diverse populations of selectable compounds as well as ready selection from such populations of small molecules attached to display peptides that bind target molecules or have desired activities (e.g. antibiotics); drugs
12/11/2003US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof
12/11/2003US20030228305 Compositions and methods for the diagnosis and treatment of tumor
12/11/2003CA2488441A1 Synthetic antibody phage libraries
12/11/2003CA2488234A1 Immunomodulatory constructs and their uses
12/11/2003CA2487939A1 Semaphorin-like proteins and methods of using same
12/11/2003CA2487932A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003CA2487895A1 Defensins: use as antiviral agents
12/11/2003CA2487513A1 Improved receptor detection
12/10/2003EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368476A2 Rearranged squamous cell carcinoma antigen genes ii
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368058A2 Viral reporter particles
12/10/2003EP1368050A2 Virus derived antimicrobial peptides
12/10/2003EP0679191B1 Detection and treatment of mutations in a cd40 ligand gene
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1130375C Insect-resistance fusion protein, its coded gene and method for producing transgenosis strain using said gene
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/09/2003US6660842 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
12/09/2003US6660830 Peptides with antiproliferative properties
12/09/2003US6660499 Nucleic acid encoding human DCR5, a protein related to DAN (Differential-screening-selected gene Aberrative in Neuroblastoma)
12/09/2003US6660275 Amplification nucleic acids
12/09/2003CA2266543C Methods and compositions for identifying receptor effectors
12/04/2003WO2003099997A2 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003WO2003099340A1 Novel chimeric cd154
12/04/2003WO2003070981A3 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
12/04/2003WO2003054017A3 Mono-and dual chemokine/cytokine constructs
12/04/2003WO2003046134A3 Expression of polypeptides in rod outer segment membranes
12/04/2003WO2003021273A3 Diagnosis of carcinomas
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002081519A9 Ifn-thy fusion protein,dna coding therefore,its preparation and application
12/04/2003WO2002036806A9 Expression vectors able to elicit improved immune response and methods of using same
12/04/2003US20030226155 Modified transferrin-antibody fusion proteins
12/04/2003US20030225251 Specificity exchangers that redirect antibodies to a pathogen
12/04/2003US20030224488 Materials and methods for preparing dimeric growth factors
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030223994 Protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the
12/04/2003CA2486918A1 Novel chimeric cd154
12/04/2003CA2486408A1 Methods and compositions for regulation and manipulation of steroidogenesis
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1366455A2 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2003EP1366175A2 Multifunctional protease inhibitors and their use in treatment of disease
12/03/2003EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer
12/03/2003EP1366077A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1366067A2 Expression technology for proteins containing a hybrid isotype antibody moiety
12/03/2003EP0625573B1 Novel dna, polypeptide coded for thereby, and method of detecting both
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/02/2003US6657055 Detection of modulators of immune response; obtain cell sample, incubate with fusion proteins, monitor cells for immune response
12/02/2003US6656906 Hybrid polypeptides with enhanced pharmacokinetic properties
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656679 Heat shock protein-based vaccines and immunotherapies
12/02/2003CA2046904C Cd4 specific recombinant antibody
11/2003
11/27/2003WO2003097871A2 Marker molecules associated with lung tumors
11/27/2003WO2003097825A2 Novel phospholipases and uses thereof
11/27/2003WO2003076469A3 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
11/27/2003WO2003070765A3 Growth hormone fusion protein
11/27/2003WO2003068802A3 Materials and methods for preparing dimeric growth factors
11/27/2003WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof
11/27/2003WO2003059378A3 Combined use of a glp-1 compound and another drug for treating dyslipidemia
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2003042249A3 Peptide purification by means of metal ion affinity chromatography
11/27/2003WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides
11/27/2003WO2003029463A3 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003016342A3 Tumor antigens for prevention and/or treatment of cancer
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2002102299A3 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
11/27/2003WO2002094881A3 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/27/2003WO2002092771A3 Specific binding proteins and uses thereof
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002077272A3 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220476 A fusion proteins comprising a cyclic peptide linked to a receptor as a cell growth factors, promoting cell proliferation, cell antiproliferative agents; soluble, potent
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
11/27/2003US20030220256 Truncated 24kDa basic fibroblast growth factor
11/27/2003US20030220248 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system
11/27/2003US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219439 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 295